Abbott to Acquire St. Jude Medical
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Rescue work underway after quakes rock Venezuela, 'high casualties' likely
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
S&P Affirms Negative Outlook on Abbott (ABT) Amid Move to Acquire St. Jude Medical (STJ)
April 28, 2016 11:38 AM EDTStandard & Poor's Ratings Services stated that its ratings on Abbott Laboratories (NYSE: ABT), including the 'A+' corporate credit and 'A-1+' commercial paper ratings, remain on CreditWatch with negative implications. The CreditWatch update follows Abbott's offer to acquire St. Jude Medical for roughly $31 billion (including $6 billion of assumed St. Jude debt). This transaction is in addition to the planned roughly $9 billion debt-funded acquisition of Alere.
"We believe that when completed, the acquisition of St. Jude Medical would significantly strengthen Abbott's position in the medical device industry as well as broaden its already very... More
Abbott (ABT), St. Jude (STJ) Deal Carries $685M Termination Fee
April 28, 2016 7:13 AM EDTAbbott (NYSE: ABT) filed the agreement terms of its proposed takeover of St. Jude Medical (NYSE: STJ). The following was noted on Thursday:
Section 10.03 Termination Fees.
(a) In the event that... More
